title: Pure red cell aplasia due to anti-erythropoietin antibodies or isoniazid? A case report from a 94-year-old man.
authors.affiliation: Department of Geriatric Nephrology, Chinese PLA General Hospital, 28 Fuxing Rd, Beijing, 100853, China.
authors.forename: Guang
authors.initials: G
authors.lastname: Yang
authors.forename: Qingli
authors.initials: Q
authors.lastname: Cheng
authors.forename: Sheng
authors.initials: S
authors.lastname: Liu
authors.forename: Xiaoying
authors.initials: X
authors.lastname: Zhang
mesh_terms: D000369:Aged, 80 and over; D000740:Anemia / Q000175:diagnosis / Q000628:therapy; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects; D001856:Bone Marrow Examination; D017707:Erythrocyte Transfusion / Q000379:methods; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D028761:Withholding Treatment
chemical_list: D000995:Antitubercular Agents; D006397:Hematinics; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; D007538:Isoniazid